Antithrombin III deficiency: Difference between revisions
No edit summary |
No edit summary |
||
Line 13: | Line 13: | ||
}} | }} | ||
'''For patient information click [[Antithrombin III deficiency (patient information)|here]]''' | '''For patient information click [[Antithrombin III deficiency (patient information)|here]]''' | ||
{{ | {{Antithrombin III deficiency}} | ||
{{CMG}} | {{CMG}} | ||
Revision as of 13:03, 21 September 2012
Antithrombin III deficiency | |
ICD-9 | 289.81 |
---|---|
OMIM | 107300 |
DiseasesDB | 783 |
MeSH | D020152 |
For patient information click here
Antithrombin III deficiency Microchapters |
Differentiating Antithrombin III deficiency from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Antithrombin III deficiency On the Web |
American Roentgen Ray Society Images of Antithrombin III deficiency |
Directions to Hospitals Treating Antithrombin III deficiency |
Risk calculators and risk factors for Antithrombin III deficiency |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Antithrombin III deficiency is a rare hereditary disorder that generally comes to light when a patient suffers recurrent venous thrombosis and pulmonary embolism.
This was first described by Egeberg in 1965.[1]
The patients are treated with anticoagulants or, more rarely, with antithrombin concentrate.
In renal failure, especially nephrotic syndrome, antithrombin is lost in the urine, leading to a higher activity of Factor II and Factor X and in increased tendency to thrombosis.
Related Chapters
References
- ↑ Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb Diath Haemorrh 1965;13:516–520. PMID 14347873.